Results 261 to 270 of about 1,025,329 (302)
Cancer stem cell specificity as new targets in breast tumor treatment. [PDF]
Oncol ResZhang Z +8 more
europepmc +1 more source
BMP antagonist CHRDL2 enhances the cancer stem-cell phenotype and increases chemotherapy resistance in colorectal cancer. [PDF]
Mol OncolClarkson E, Lewis A.
europepmc +1 more source
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits. [PDF]
Int J OncolChung SS, Giehl N, Wu Y, Vadgama JV.
europepmc +1 more source
[Corrigendum] Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways. [PDF]
Int J Mol MedCao L +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2016
The cancer stem cell model in solid tumors has evolved significantly from the early paradigm shifting work highlighting parallels between the stem cell hierarchy in hematologic malignancies and solid tumors. Putative stem cells can dedifferentiated, be induced by context, and be the result of accumulated genetic mutations.
Wendy A, Woodward, Richard P, Hill
openaire +2 more sources
The cancer stem cell model in solid tumors has evolved significantly from the early paradigm shifting work highlighting parallels between the stem cell hierarchy in hematologic malignancies and solid tumors. Putative stem cells can dedifferentiated, be induced by context, and be the result of accumulated genetic mutations.
Wendy A, Woodward, Richard P, Hill
openaire +2 more sources
Journal of Clinical Oncology, 2008
Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible ...
Cheong J, Lee +2 more
openaire +2 more sources
Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible ...
Cheong J, Lee +2 more
openaire +2 more sources
Current Protocols in Stem Cell Biology, 2008
AbstractThis unit describes protocols for working with colon cancer stem cells. To work with these cells one must start by generating single‐cell suspensions from human colon cancer tissue. These cell suspensions are sorted using flow cytometry–assisted cell sorting to fractionate the cells into tumor‐initiating and nontumor‐initiating subsets.
Antonija, Kreso +1 more
openaire +2 more sources
AbstractThis unit describes protocols for working with colon cancer stem cells. To work with these cells one must start by generating single‐cell suspensions from human colon cancer tissue. These cell suspensions are sorted using flow cytometry–assisted cell sorting to fractionate the cells into tumor‐initiating and nontumor‐initiating subsets.
Antonija, Kreso +1 more
openaire +2 more sources
Gut, 2007
Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106–130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options ...
L, Ricci-Vitiani +4 more
openaire +2 more sources
Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106–130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options ...
L, Ricci-Vitiani +4 more
openaire +2 more sources
Expert Opinion on Therapeutic Targets, 2007
Recent evidence has demonstrated the existence of a small subset of the tumour mass that is wholly responsible for the sustained growth and propagation of the tumour. This cancer stem cell (CSC) compartment is also likely to be responsible both for disease relapse and the resistance to therapy that often accompanies relapse.
Brynn T, Kvinlaug, Brian J P, Huntly
openaire +2 more sources
Recent evidence has demonstrated the existence of a small subset of the tumour mass that is wholly responsible for the sustained growth and propagation of the tumour. This cancer stem cell (CSC) compartment is also likely to be responsible both for disease relapse and the resistance to therapy that often accompanies relapse.
Brynn T, Kvinlaug, Brian J P, Huntly
openaire +2 more sources
STEM CELLS, 2012
Colorectal cancer (CRC) is one of the most commonly diagnosed and lethal cancers worldwide. It is a multistep process that requires the accumulation of genetic/epigenetic aberrations. There are several issues concerning colorectal carcinogenesis that remain unanswered, such as the cell of origin and the type of cells that propagate the tumor after its ...
Aristides G, Vaiopoulos +3 more
openaire +2 more sources
Colorectal cancer (CRC) is one of the most commonly diagnosed and lethal cancers worldwide. It is a multistep process that requires the accumulation of genetic/epigenetic aberrations. There are several issues concerning colorectal carcinogenesis that remain unanswered, such as the cell of origin and the type of cells that propagate the tumor after its ...
Aristides G, Vaiopoulos +3 more
openaire +2 more sources